Thats when the ICD 10 code for medication monitoring comes into play
From this source population, our study population was selected, consisting exclusively of individuals with at least one redeemed prescription for GLP-1a [Anatomical Therapeutic Chemical (ATC) system: A10BJ] or DPP-4i [ATC code: A10BH] for type-2 diabetes
And document the medication plan using Z79.899 or the relevant drug class code
Accurate medication coding particularly for long-term use is critical for FY2024+ encounters and beyond
Subject demographics (for example: age, sex, self-identified race), lab values (for example: HbA1c, BMI, liver enzymes), and some medication information (GLP-1 M, other drugs used to treat T2D, and NSAIDs) and presence or absence of diabetes-associated complications (for example: chronic kidney disease, cardiovascular disease) were extracted as prediction features
Along this line, a recent large case-control study from 2024 including 162,253 obese patients treated with GLP-1 RAs and a matched group of untreated patients found an association between GLP-1 RAs and increased risk of depression, anxiety and suicidal behavior [10]